PubMed HealthSearch

PubMed · 6525532

Computer based instruments for laboratory environments.

Abstract

The personal computer is viewed as an all-purpose laboratory instrument and work station. Popular architectures are examined with regard to advantages and limitations, and applications discussed in terms of "stand alone" environments, situations requiring passive interfaces, and those employing intelligent configurations. A new hardware/software architecture is presented which is highly modular, and which supports rapid instrumental reconfiguration, high throughput (information capacity), and ease of use.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

A Stundel, G Silverman, M C Chen, R J O'Connell. 1984. Computer based instruments for laboratory environments.. https://doi.org/10.1016/0361-9230(84)90044-3

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Avatars in space.

Explore the source record for details and available documents.

Computers

Structure-based inhibitor design.

Time and costs associated with the discovery of new drugs have been significantly reduced by enzyme structure-based approaches to the discovery of new chemotherapeutic agents. However, fundamental components of the overall approach continue to rely on technologies which, by their nature, involve relatively random processes (i.e., combinatorial chemistry and high-throughput screening). Thus, the efficiency of the drug discovery process potentially could be further improved through better use of structural information. In this regard, three-dimensional structures of enzymes are now being solved at high resolution and/or in conformations that provide data that should be more useful for inhibitor design or discovery. Scientists are beginning to appreciate the importance of water as a possible competitor of inhibitors for binding to target enzymes. New computational algorithms are improving the efficiency of identifying flexible inhibitors from among the large numbers of compounds in chemical databases. Also, tools of molecular genetics together with structures of target enzymes are likely to be used more frequently in dealing with the development of resistance to novel chemotherapeutic agents. Instead of detailing success stories in structure-based drug discovery, the following article considers how future efforts to discover or design new drugs may increasingly rely on information about molecular targets and less on data acquired via approaches involving random methodologies.

Computers